Alerts will be sent to your verified email
Verify Email
AARTIDRUGS
|
Aarti Drugs
|
SMS Pharmaceuticals
|
Solara Active Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
APIs Production Capacity
|
45511.0 MTPA | n/a | n/a |
|
R&D as a % of Total Sales
|
1.93 % | 2.4 % | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
18.02 % | 9.41 % | -10.41 % |
|
5yr average Equity Multiplier
|
1.97 | 1.92 | 1.99 |
|
5yr Average Asset Turnover Ratio
|
1.09 | 0.64 | 0.54 |
|
5yr Avg Net Profit Margin
|
8.24 % | 7.52 % | -7.28 % |
|
Price to Book
|
2.48 | 4.19 | 2.33 |
|
P/E
|
18.26 | 36.22 | 456.0 |
|
5yr Avg Cash Conversion Cycle
|
79.88 Days | 95.74 Days | 28.67 Days |
|
Inventory Days
|
69.48 Days | 117.18 Days | 111.94 Days |
|
Days Receivable
|
111.3 Days | 94.73 Days | 95.97 Days |
|
Days Payable
|
97.75 Days | 94.13 Days | 146.85 Days |
|
5yr Average Interest Coverage Ratio
|
9.61 | 4.95 | 0.25 |
|
5yr Avg ROCE
|
21.16 % | 12.07 % | 2.1 % |
|
5yr Avg Operating Profit Margin
|
14.01 % | 17.65 % | 9.63 % |
|
5 yr average Debt to Equity
|
0.46 | 0.54 | 0.7 |
|
5yr CAGR Net Profit
|
-9.72 % | 2.03 % | -69.98 % |
|
5yr Average Return on Assets
|
9.12 % | 4.9 % | -3.67 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
54.72 % | 68.07 % | 42.01 % |
|
Share Pledged by Promoters
|
0.0 | 34.65 % | 35.32 % |
|
Change in Promoter Holding (3 Yrs)
|
-5.05 % | 3.9 % | 1.61 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
6.73 % | 2.88 % | -1.37 % |
|
Aarti Drugs
|
SMS Pharmaceuticals
|
Solara Active Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|